Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurélie Thedrez

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Medecine Sciences : M/S|June 19, 2014
[Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape]Véronique Catros, Benoit Dessarthe, Aurélie Thedrez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapyAurélie Thedrez, Christelle Harly, Alexis Morice, et al.
Plos One|May 30, 2013
A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patientsAurélie Thedrez, Vincent Lavoué, Benoit Dessarthe, et al.
Immunological Reviews|February 13, 2007
Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?Aurélie Thedrez, Caroline Sabourin, Julie Gertner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2013
CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cellsBenoît Dessarthe, Aurélie Thedrez, Jean-Baptiste Latouche, et al.
Atherosclerosis|September 6, 2016
PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemiaRodrigo Alonso, Pedro Mata, Ovidio Muñiz, et al.
Clinical Science (London, England : 1979)|January 22, 2017
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesGilles Lambert, Aurélie Thedrez, Mikaël Croyal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
International Journal of Cancer|November 19, 2011
Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapyVincent Lavoué, Florian Cabillic, Olivier Toutirais, et al.
Atherosclerosis|May 2, 2021
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells functionStéphane Ramin-Mangata, Aurélie Thedrez, Brice Nativel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medecine Sciences : M/S|June 19, 2014
[Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape]Véronique Catros, Benoit Dessarthe, Aurélie Thedrez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapyAurélie Thedrez, Christelle Harly, Alexis Morice, et al.
Plos One|May 30, 2013
A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patientsAurélie Thedrez, Vincent Lavoué, Benoit Dessarthe, et al.
Immunological Reviews|February 13, 2007
Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?Aurélie Thedrez, Caroline Sabourin, Julie Gertner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2013
CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cellsBenoît Dessarthe, Aurélie Thedrez, Jean-Baptiste Latouche, et al.
Atherosclerosis|September 6, 2016
PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemiaRodrigo Alonso, Pedro Mata, Ovidio Muñiz, et al.
Clinical Science (London, England : 1979)|January 22, 2017
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodiesGilles Lambert, Aurélie Thedrez, Mikaël Croyal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
International Journal of Cancer|November 19, 2011
Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapyVincent Lavoué, Florian Cabillic, Olivier Toutirais, et al.
Atherosclerosis|May 2, 2021
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells functionStéphane Ramin-Mangata, Aurélie Thedrez, Brice Nativel, et al.
Pageof 2